Dear user, the application need JavaScript support. Please enable JavaScript in your browser.

You are browsing as a GUEST

You search for a phrase ""Mesh:C-Reactive Protein/analysis"" according to the criterion: Subject Terms

Showing 1-6 from 6 results
Title :
Efficacy of Biological-Targeted Treatments in Takayasu Arteritis Multicenter, Retrospective Study of 49 Patients
Authors :
Mekinian, Arsene
Comarmond, Cloe
Resche-Rigon, Matthieu
Mirault, Tristan
Kahn, Jean Emmannuel
Lambert, Marc
Sibilia, Jean
Neel, Antoine
Cohen, Pascal
Hie, Miguel
Berthier, Sabine
Marie, Isabelle
Lavigne, Christian
Anne Vandenhende, Marie
Muller, Geraldine
Amoura, Zahir
Devilliers, Herve
Abad, Sebastien
Hamidou, Mohamed
Guillevin, Loic
Dhote, Robin
Godeau, Bertrand
Messas, Emmanuel
Cacoub, Patrice
Fain, Olivier
Saadoun, David
Show more
Subject Terms :
Mesh:Adalimumab/therapeutic use
Mesh:Middle Aged
Mesh:C-Reactive Protein/analysis
Mesh:Infliximab/therapeutic use
Mesh:Tumor Necrosis Factor-alpha/antagonists & inhibitors
Mesh:Disease-Free Survival
Mesh:Infliximab/adverse effects
Mesh:Prednisone/therapeutic use
Mesh:Proportional Hazards Models
Mesh:Antirheumatic Agents/therapeutic use
Mesh:Antirheumatic Agents/adverse effects
Mesh:Humanized/adverse effects
Sciences du Vivant [q-bio]
Mesh:Humanized/therapeutic use
Mesh:Drug Therapy
Mesh:Takayasu Arteritis/blood
Mesh:Treatment Outcome
Mesh:Drug Resistance
Takayasu arteritis
Mesh:Takayasu Arteritis/diagnostic imaging
Mesh:Drug Evaluation
Mesh:Molecular Targeted Therapy*/adverse effects
Mesh:Young Adult
biological therapy
Mesh:Blood Sedimentation
treatment outcome
Mesh:Retrospective Studies
Mesh:Etanercept/therapeutic use
Mesh:Takayasu Arteritis/drug therapy
Mesh:Etanercept/adverse effects
Mesh:Adalimumab/adverse effects
    Showing 1-6 from 6 results

    We use cookies to help identify your computer so we can tailor your user experience, track shopping basket contents and remember where you are in the order process.